is a collaborative coalition of leading molecular diagnostics companies and laboratories that aims to raise awareness about comprehensive genomic profiling (CGP) for advanced cancer patients. The coalition seeks to educate stakeholders about the value of CGP tests in all tumor types to assure appropriate use in the patient journey to inform medical management and improve clinical outcomes. Our membership is dedicated to sharing the clinical utility and economic value of CGP with healthcare stakeholders, thereby increasing access to this innovative technology in the United States.